Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
gallbladder wall thickness | measured thickness of the gallbladder wall | The report gives gallbladder wall thickness in millimeters. | Objective | Hepatobiliary, pancreatic and nutrition findings |
glucose variability | extent of fluctuation in measured glucose | The sensor report documents greater glucose variability overnight. | Objective | Electrolytes, acid-base and metabolic testing |
gradient | difference in pressure between two measured sites | The echocardiogram reports the mean valve gradient. | Objective | Tracings, rhythm and diagnostic measurements |
hemodynamically stable | circulatory measurements and perfusion remained adequate in the stated interval | The patient remained hemodynamically stable during the recorded observation. | Assessment | Volume, organ function and illness severity |
hepatitis B viral load | amount of hepatitis B virus DNA measured in a specified sample | Hepatitis B viral load was reported with units and the lower reporting limit. | Objective | Molecular testing, serology and culture findings |
hepatitis C RNA | viral RNA measured to assess current hepatitis C viremia | Hepatitis C RNA was reported with its detection qualifier. | Objective | Molecular testing, serology and culture findings |
HIV RNA viral load | measured amount of HIV RNA in the specimen | HIV RNA viral load was recorded in copies per milliliter with the collection date. | Objective | Molecular testing, serology and culture findings |
home weight monitoring | repeated measurement of body weight under comparable home conditions | Agree on the timing for home weight monitoring and how changes should be communicated. | Plan | Oncology, rehabilitation and chronic disease follow-up |
hydroxyitraconazole | active itraconazole metabolite measured in some drug assays | The laboratory lists hydroxyitraconazole separately on the antifungal drug report. | Objective | Drug levels - named analytes and exposure reports |
impedance | resistance to alternating current in this measurement context | Lead impedance is stable on pacemaker interrogation. | Objective | Tracings, rhythm and diagnostic measurements |
interstitial glucose lag | delay between blood glucose change and the sensor's interstitial measurement | Interstitial glucose lag was considered during the rapid change after exercise. | Objective | Glucose monitoring, endocrine testing and urine studies |
interval discordance | change over time differs between measures or sources | The interval discordance between symptoms and imaging remains unexplained. | Assessment | Diagnostic reasoning and strength of evidence |
interval monitoring | planned repeat measurement during ongoing care | Specify the analyte and timing for interval monitoring. | Plan | Monitoring actions, escalation and result communication |
kappa-to-lambda ratio | ratio of measured kappa and lambda light chains | The kappa-to-lambda ratio was interpreted against the appropriate assay reference. | Objective | Glucose monitoring, endocrine testing and urine studies |
| metabolite measured in blood to assess several clinical processes | Venous lactate declined from 3.6 to 2.2 mmol/L. | Objective | Electrolytes, acid-base and metabolic testing | |
late-night salivary cortisol | saliva cortisol measured at the specified late-night collection time | Late-night salivary cortisol was reviewed with the patient's usual sleep schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
length | recumbent linear measurement in an infant | Recumbent length was measured on the infant board. | Objective | Infants, growth and feeding observations |
limited sampling strategy | specified subset of timed measurements used to estimate an exposure metric | The report names the validated limited sampling strategy used for the AUC estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
lipase | enzyme commonly measured in assessment of pancreatic injury | Serum lipase is reported as a multiple of the upper reference limit. | Objective | Hepatobiliary, pancreatic and nutrition findings |
lithium | mood stabilizer measured with a timed blood concentration | The lithium level is documented with the evening dose and morning draw times. | Objective | Drug levels - named analytes and exposure reports |
measurable disease | disease meeting specified criteria for reproducible measurement | Measurable disease was identified using the criteria named in the report. | Assessment | Cancer, treatment response and transplant assessment |
measuring syringe | graduated syringe used to measure a prescribed liquid volume | Demonstrate the marking on the oral measuring syringe. | Plan | Therapies, devices and interdisciplinary care |
midarm circumference | measurement around the upper arm at a defined level | The dietitian recorded midarm circumference at the same landmark as last week. | Objective | Hepatobiliary, pancreatic and nutrition findings |
model fit | agreement between a model and measured observations | Review the model fit against the timed concentrations. | Plan | Drug levels - verification and documentation |
monitor | observe a measure over time | Monitor the trend in morning weights. | Plan | Investigation and monitoring |